Jefferies analyst Brandon Couillard lowered the price target on Myriad Genetics (NASDAQ: MYGN) to $19.00 (from $23.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change

Myriad Genetics (MYGN) PT Lowered to $23 at SVB LeerinkFebruary 7, 2020 8:59 AM Myriad Genetics (MYGN) PT Lowered to $20 at Piper SandlerFebruary 7, 2020 8:09 AM Myriad Genetics (MYGN) announces Mark Capone has resigned as President and CEOFebruary 6, 2020 4:14 PM Myriad Genetics (MYGN) Misses Q2 EPS by 8c, Guidance MissesFebruary 6, 2020 4:13 PM